The role of NLRP3 inflammasome in sepsis: A potential therapeutic target

W He, H Dong, C Wu, Y Zhong, J Li - International Immunopharmacology, 2023 - Elsevier
Sepsis is the host immune imbalance following infection and leads to organ dysfunction,
with highly complicated pathophysiology. To date, sepsis still lacks effective therapies with …

Suppression of lncRNA NLRP3 inhibits NLRP3-triggered inflammatory responses in early acute lung injury

D Luo, W Dai, X Feng, C Ding, Q Shao, R Xiao… - Cell Death & …, 2021 - nature.com
Acute lung injury (ALI) is a common lung pathology that is accompanied by alveolar
macrophage (AM) activation and inflammatory response. This study investigated the role of …

NLRP3 inflammasome inhibition attenuates sepsis-induced platelet activation and prevents multi-organ injury in cecal-ligation puncture

DC Cornelius, OK Travis, RW Tramel… - PLoS …, 2020 - journals.plos.org
Sepsis is characterized by organ dysfunction due to a dysregulated immune response to
infection. Currently, no effective treatment for sepsis exists. Platelets are recognized as …

[HTML][HTML] NLRP3 inflammasome as a therapeutic target for atherosclerosis: a focus on potassium outflow

YJ Jin, ZY An, ZX Sun, XC Liu - Reviews in Cardiovascular Medicine, 2022 - imrpress.com
Atherosclerosis is a risk factor for various cardiovascular diseases, and is linked to high
rates of morbidity and mortality across the globe. Although numerous complex processes …

Salmonella Enteritidis T1SS protein SiiD inhibits NLRP3 inflammasome activation via repressing the mtROS-ASC dependent pathway

Y Guo, D Gu, T Huang, A Li, Y Zhou, X Kang… - PLoS …, 2023 - journals.plos.org
Inflammasome activation is an essential innate immune defense mechanism against
Salmonella infections. Salmonella has developed multiple strategies to avoid or delay …

Inhibition of sphingosine-1-phosphate receptor 3 suppresses ATP-induced NLRP3 inflammasome activation in macrophages via TWIK2-mediated potassium efflux

Y Wang, C Wang, Q He, G Chen, J Yu, J Cang… - Frontiers in …, 2023 - frontiersin.org
Background Inhibition of sphingosine kinase 1 (SphK1), which catalyzes bioactive lipid
sphingosine-1–phosphate (S1P), attenuates NLRP3 inflammasome activation. S1P exerts …

Novel 1-hydroxy phenothiazinium-based derivative protects against bacterial sepsis by inhibiting AAK1-mediated LPS internalization and caspase-11 signaling

C Yuan, K Ai, M Xiang, C Xie, M Zhao, M Wu, H Li… - Cell Death & …, 2022 - nature.com
Sepsis is a life-threatening syndrome with disturbed host responses to severe infections,
accounting for the majority of death in hospitalized patients. However, effective medicines …

Ulinastatin protects against sepsis‑induced myocardial injury by inhibiting NLRP3 inflammasome activation

J Qiu, X Xiao, X Gao, Y Zhang - Molecular Medicine …, 2021 - spandidos-publications.com
Myocardial injury is the primary manifestation of multiple organ dysfunction during sepsis,
however, the mechanisms underlying sepsis‑induced myocardial injury remain unclear …

[HTML][HTML] Protectin conjugates in tissue regeneration 1 inhibits macrophage pyroptosis by restricting NLRP3 inflammasome assembly to mitigate sepsis via the cAMP …

MQ Ma, SS Zheng, HL Chen, HB Xu, DL Zhang… - Laboratory …, 2023 - Elsevier
Protectin conjugates in tissue regeneration 1 (PCTR1) is a novel anti-inflammatory and
proresolving lipid mediator biosynthesized from docosahexaenoic acid. Excessive activation …

Akkermansia muciniphila attenuates LPS-induced acute kidney injury by inhibiting TLR4/NF-κB pathway

J Shi, F Wang, L Tang, Z Li, M Yu, Y Bai… - FEMS Microbiology …, 2022 - academic.oup.com
Acute kidney injury (AKI) is a global public health hazard with high morbidity and mortality.
Sepsis accounts for nearly half of all causes of AKI. Scientists have made a great effort to …